Ben is a Principal in the Medicxi Investment team. Prior to joining Medicxi, Ben spent over twenty years leading small molecule discovery projects in various R&D organisations including the Drugs for Neglected Diseases initiative (DNDi, Geneva), Addex Therapeutics (Geneva) and UCB (Cambridge, UK) as well as co-founding the early-stage start-ups AiDD SA and MPC Therapeutics SA.
Ben received a MChem from University of Wales Swansea, a PhD in organic chemistry from Imperial College London and an EMBA from IE Business School, Madrid
University of Wales Swansea, Imperial College London, IE Business School
Music, cooking, snowboarding
Marie Beaucourt email@example.com